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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness of mobile-based technologies to support communication of healthcare information and management of care,
on clients’ health and well-being, as well as unintended consequences and resources use, compared to standard practice.
B A C K G R O U N D
The provision of healthcare at a distance, through telemedicine
applications, can facilitate universal health coverage, decreasing
health and social inequalities (Wootton 2008). Thewidespread use
of information and communication technologies can potentially
expand the use of telemedicine approaches to overcome health
systems challenges associated with accessing care and coverage of
services.
Description of the condition
Access to healthcare is essential for the promotion of health and the
management of diseases and chronic conditions. Extensive health-
care coverage traditionally leads to improved access to required
healthcare and improved population health, especially for those
from more deprived socio-economic backgrounds (Moreno-Serra
2012) and rural and remote areas (Jamison 2013). Mobile access
to healthcare and health-related information becomes vital in con-
texts where access to healthcare is scarce, as those needing clinical
information might be particularly vulnerable to ineffective treat-
ment (Royston 2015).
Description of the intervention
Telemedicine is defined as the use of information and communi-
cation technologies for medical diagnostic, monitoring, and thera-
peutic purposes, when participants are separated by distance, time,
or both, with the ultimate goal of improving the health of indi-
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viduals and communities (Hersh 2006). Although telemedicine
and telehealth have been conceptualised separately, with the latter
being a broader term that also encapsulates non-clinical activities
such as professional education, they are often used synonymously
(Hersh 2006; WHO 2016). Mobile health (mHealth) has been
more recently defined and refers to the use of mobile telecommu-
nication technologies for delivering healthcare (Steinhubi 2013).
The exchange of information can occur synchronously (when in-
teractions happen in real time) or asynchronously (when there is
a lag between the clinical information being transmitted and the
response) (WHO 2016), and through different channels, includ-
ing videoconferencing, mobile applications, and secure messag-
ing (Kruse 2017). The most common examples of telemedicine
services are store and forward services, where medical data are
transmitted to a healthcare provider for offline assessment; remote
monitoring services, where a person is monitored at a distance by
a healthcare provider through the use of technologies; and interac-
tive services, where there is real-time interaction between a person
and their healthcare provider (WHO 2012; WHO (in press)).
A global survey on eHealth was recently conducted by the World
Health Organization (WHO) (WHO 2016), in which the terms
telehealth and telemedicine were used interchangeably. Results
showed that 57% of 122 surveyed countries had telehealth as
part of the national eHealth policy or strategy (70 countries), and
22% (27 countries) had a dedicated national telehealth policy or
strategy (WHO 2016). According to the surveyed countries, the
most common areas where telehealth was used were teleradiology,
telepathology, remote patient monitoring and teledermatology, all
of which were in use in more than half of the surveyed countries
(WHO 2016). Of those, teleradiology programmes were most es-
tablished, whereas the other programme types were mainly infor-
mal or at the pilot stage.
In a bid to maximise the coverage of healthcare services, decrease
the costs associated with providing healthcare, and optimise the
shortage of healthcare professionals, governments and healthcare
agencies all over the world have been funding telehealth pro-
grammes, in high-, middle- and low-income countries. Some ex-
amples include: the technology enabled care services programme
in England (NHS Commissioning Assembly 2015); the Scottish
Centre for Telehealth and Telecare (SCTT 2017); telehealth pilot
programmes in Australia (Australian Government Department of
Health 2017); telehealth services provided within the Medicare
programme in the USA (MedPAC 2016); the Asia eHealth infor-
mation network (AeHIN 20017); and the KwaZulu-Natal expe-
rience in South Africa (Mars 2012).
How the intervention might work
By enabling exchange of clinical information that otherwise
might not be possible, telemedicine promotes access to health-
care services, overcoming barriers such as the existence of ser-
vices and timeliness of access. The main benefits associated with
telemedicine are improved access to healthcare, increased speed
at which it can be accessed, and cost reduction (Wootton 2008).
This is particularly relevant for settings with limited healthcare
resources, for instance low- and middle-income countries and re-
mote areas. By bringing together healthcare providers and clients
who otherwise might not be able to exchange clinical informa-
tion, telemedicine increases the uniformity of clinical practice, pro-
motes universal health coverage, and decreases health and social
inequalities. Techonological advances and better telecommunica-
tion systems enable broader and less expensive access to healthcare
delivered remotely, making the intervention more accessible.
Notwithstanding the possibilities, telemedicine applications have
been inconsistently implemented and with varying degrees of suc-
cess, which can be explained by technological challenges, legal con-
siderations, human and cultural factors, and uncertainty about its
economic benefits and cost-effectiveness (WHO 2011). A global
eHealth survey conducted recently reported that lack of funding,
infrastructure, prioritisation, and legislation or regulations were
themost commonly cited barriers to implementing telehealth pro-
grammes (WHO 2016). These barriers can only be overcome
by the implementation of comprehensive regulatory guidelines,
driven both by governmental and professional medical organisa-
tions; legislation on confidentiality, privacy and liability; and the
involvement of all stakeholders in designing, implementing and
evaluating telemedicine applications, focusing on the safety and
the effectiveness of applications (Agboola 2016; WHO 2011).
Why it is important to do this review
The rapid progress in information and communication technolo-
gies means that the field of telemedicine is also hastily evolving.
Despite its potential and the exponential growth of telemedicine
applications in recent decades, there are still unanswered questions
about its effectiveness (Agboola 2016;WHO2016). The rationale
for conducting this review is to assess the effectiveness of mobile-
based technologies to support communication of healthcare in-
formation. Although these technologies are now ubiquitous, their
rapid expansion has not been accompanied by a close assessment
of their impact, which led the WHO to commission guidelines
that aim to inform investments of digital health applications for
strengthening health systems. This is one of a suite of six Cochrane
Reviews that will contribute to those guidelines. We aim to assess
the effectiveness of telemedicine not only on relevant clinical out-
comes, but also acceptability, satisfaction, resources use and unin-
tended consequences. Research into unintended consequences has
been particularly neglected, but can provide crucial information
for the implementation of successful telemedicine programmes.
O B J E C T I V E S
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To assess the effectiveness of mobile-based technologies to sup-
port communication of healthcare information and management
of care, on clients’ health and well-being, as well as unintended
consequences and resources use, compared to standard practice.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised trials and cluster randomised trials.
We will include full-text studies, conference abstracts, and unpub-
lished data. We will include studies irrespective of their publica-
tion status and language of publication.
Types of participants
• Clients receiving healthcare accessible via mobile devices.
• All types of healthcare providers (i.e. professionals,
paraprofessionals and lay health workers), communicating and
providing client care through mobile-based technologies.
We will include participants regardless of their location, setting,
diagnoses, conditions or demographic factors such as age.
Types of interventions
We will include trials comparing communication and manage-
ment of care through a mobile device with standard practice. By
mobile-based communication from client to healthcare provider,
we mean the exchange of communication and provision of health-
care information and services at a distance (WHO2012), in which
communication is conducted between remote clients engaging
with health services and healthcare providers. We will focus exclu-
sively on the provision of healthcare information where the per-
son’s inquiry receives a response in real-time or response is as im-
mediate as appropriate clinically. Standard practice is defined as
the usual care provided in the setting where the study was con-
ducted, which could include providing care or engaging with the
client through face-to-face communication or other non-digital
channels or referring the client to another provider.
We will focus exclusively on clinical information that can be ex-
changed over wireless and mobile technologies, as well as mobile
phones of any kind (but not analogue landline telephones), lap-
tops, tablets, personal digital assistants, and smartphones. Com-
munication channels via mobile device can include text messag-
ing, video messaging, social media, voice calls, voice over internet
protocol (VoIP), and videoconferencing, through software such as
Skype, WhatsApp, or Google Hangouts.
We will include:
• studies in which the clients employ mobile-based
technologies to engage with provider(s); this could also include
partners, family members or other informal support providers
engaging with providers on behalf of others;
• studies in which the provider(s) offering care is at a
different location from the client;
• studies in which the client transmits clinical information via
a mobile device; and
• studies in which the provider(s) offering guidance responds
in real-time, defined as sufficiently immediate or as clinically
appropriate.
We will include studies where mobile-based technologies were
used for monitoring, consultation or delivering treatment, as long
as there was clinical information exchanged between client and
provider, and feedback given by the provider. We will include
studies where the type of communication device that was used to
transmit the clinical information is unknown, since the specificity
of the type of communication device is not often reported.
We will include all health issues and will not restrict the content
of clinical health information exchanged. We will include studies
where the digital component of the intervention was delivered
as part of a wider package if we have judged it to be the major
component of the intervention.
We will exclude:
• Pilot and feasibility studies (pilot study defined as “a version
of the main study that is run in miniature to test whether the
components of the main study can all work together” (Arain
2010) and feasibility study defined as “pieces of research done
before a main study” (Arain 2010)).
• Studies that compared different technical specifications of
telecommunication technologies, e.g. different communication
channels, software, etc.
• Studies in which the client used fully automated services to
self-care or access clinical information without having any
contact with a healthcare provider (e.g. webMD).
• Studies in which the use of telecommunications technology
was not linked to direct client care.
• Studies in which the intervention consisted of client
monitoring systems in which the client received only an
automated voice response.
• Studies in which the intervention consisted of routine
communication to the healthcare provider as part of usual
follow-up care.
• Studies in which clients used an automated service to relay
clinical information, without having any other interaction with
the healthcare provider (e.g. client is fitted with a system that will
send a message if glycated haemoglobin (HbA1c) drops below a
certain range and there is no feedback from the healthcare
provider), where the client has already had in-person contact
with a healthcare provider.
• Studies in which there was no transfer/communication of
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clinical information between client and provider. For example, a
portable medical device is excluded if it does not transmit clinical
information to a provider. The key functionality is that there is
an exchange of clinical information between client and healthcare
providers; the device/health equipment used for obtaining the
clinical information to be exchanged is not as relevant.
• Studies in which providers engage with clients through
predefined scheduled calls, where there is no mention of the
client being able to contact the healthcare provider in between.
• Studies that explicitly used non-mobile devices to transfer
clinical information, such as computers, videoconferencing,
landlines, etc. We will not exclude studies based on the type of
device or health equipment that was used to obtain the clinical
information.
Types of outcome measures
Main outcomes
1. Time between presentation and appropriate response
(includes diagnosis, referral or treatment) by provider, including
change in time for clients to receive/access health services and
information.
2. Clients health status and well-being, using validated
measures, such as the Notthingham Health Profile or the SF-36
(McDowell 2006).
Other outcomes
1. Clients utilisation of healthcare services (e.g. reduced
emergency room visits).
2. Clients acceptability of and satisfaction with the
intervention; this will include both objective measures, such as
the number of dropouts not explained by other reasons, and self-
reported acceptability and satisfaction, measured with a validated
scale, such as the Patient Satisfaction Scale (La Monica 1986).
3. Healthcare provider acceptability of and satisfaction with
the intervention; this will include both objective measures, such
as the number of dropouts not explained by other reasons, and
self-reported acceptability and satisfaction, measured with a
validated scale, such as the Physician Worklife Survey (Konrad
1999).
4. Resource use, including cost to the client and cost to the
service (e.g. human resources/time, supplies and equipment).
This measure will need to be pre-specified and available directly
from the results section.
5. Unintended consequences. These could include:
misreading or misinterpretation of data; transmission of
inaccurate data; loss of verbal and non-verbal communication
cues, including between provider and client; issues of privacy and
disclosure; affecting interpersonal relationships; negative impacts
on equity; failure or delay in the message delivery.
Search methods for identification of studies
Electronic searches
An information specialist developed the search strategies in con-
sultation with the review authors and WHO content experts. We
will use a cut-off search date of 2000, based on the increased avail-
ability and penetration of mobile devices used for telemedicine
from that date (ITU 2017). Appendix 1 lists the search strategy
for MEDLINE. We will search the following databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL; latest issue), in the Cochrane Library;
• MEDLINE Ovid;
• Embase Ovid;
• POPLINE; and
• WHO Global Health Library.
Searching other resources
Trial registries
We will search clinicaltrials.gov (clinicaltrials.gov) and the World
Health Organization International Clinical Trials Registry Plat-
form (who.int/ictrp) trial registries.
Grey literature
We will conduct a grey literature search to identify studies not
indexed in the databases listed above. We will search for relevant
systematic reviews and primary studies on similar topics using
Epistemonikos (epistemonikos.org), which is a database of health
evidence and a large source of health-related systematic reviews.
We will search all the contributed content in mHealthEvidence (
mhealthevidence.org), a database of global literature on mHealth.
We will contact authors of relevant studies and reviews to clarify
reported published information and to seek unpublished results
or data. We will contact researchers with expertise relevant to the
review topic. Additionally, the WHO will issue a call for papers
through popular digital health communities of practice such as the
Global Digital Health Network and ImplementingBest Practices,
to identify additional primary studies as well as grey literature.
Data collection and analysis
Selection of studies
We will download all titles and abstracts retrieved by electronic
searching to a reference management database and remove dupli-
cates. For title and abstract screening, we will use a machine learn-
ing classifier that is able to assign a probability score that a given
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record describes, or does not describe, a randomised trial (Wallace
2017). Titles and abstracts of studies with a 10% probability or
greater of being a randomised trial will be screened by two review
authors (of BB, NH, NM), and those with less than 10% proba-
bility of being a randomised trial will be screened by one review
author. We will retrieve the full-text study reports/publications
and two review authors (of BB, NH, NM) will independently
screen the full-text and identify studies for inclusion and identify
and record reasons for exclusion of the ineligible studies. We will
resolve any disagreement through discussion or, if required, we
will consult a third review author (DGB or SS).
We will list studies that initially appeared tomeet the inclusion cri-
teria but that we later excluded in the ’Characteristics of excluded
studies’ table. We will collate multiple reports of the same study so
that each study rather than each report is the unit of interest in the
review. We will also provide any information we can obtain about
ongoing studies. We will record the selection process in sufficient
detail to complete a PRISMA flow diagram (Liberati 2009).
Data extraction and management
We will use the EPOC standard data collection form and adapt
it for study characteristics and outcome data (EPOC 2017a); we
will pilot the form on at least one study in the review. Two review
authors (of BB,NH,NM)will independently extract the following
study characteristics from the included studies.
1. Methods: study design, unit of allocation, location and
study setting, withdrawals.
2. Participants: number, mean age, age range, gender,
inclusion criteria, exclusion criteria, other relevant characteristics.
3. Interventions: function of the intervention (monitoring,
consultation, therapy), intervention components (including type
of technology and mode of delivery, frequency of data
transmission),comparison, fidelity assessment. For this review,
we will define monitoring as to keep track or record the progress
of symptoms or a condition over a period of time; consultation
as an exchange between the healthcare provider and the client,
where the latter’s health status is discussed and guidance,
support, or information are provided; and therapy as the
ongoing management and care of a client, to counteract a disease
or disorder.
4. Outcomes: main outcomes specified and collected, time
points reported.
5. Notes: funding for trial, ethical approval.
Two review authors (of BB, NH, NM) will independently extract
outcome data from included studies. We will contact authors of
included studies to seek missing data. We will note in the ’Char-
acteristics of included studies’ table if outcome data were reported
in an unusable way. We will resolve disagreements by consensus or
by liaising with a third review author (DGB or SS).We will group
the studies by health condition being targeted. We will create a
miscellaneous category for studies focusing on rare conditions and
single studies of a condition, for which we will extract basic study
information and descriptive data, but not outcome data.
Assessment of risk of bias in included studies
Two review authors (of BB, NH, NM) will independently assess
risk of bias for each study using the criteria outlined in theCochrane
Handbook for Systematic Reviews of Interventions Section (Higgins
2017), and guidance from the EPOC group (EPOC 2017b). Any
disagreement will be resolved by discussion or by liaising with a
third review author (DGB or SS). We will assess the risk of bias
according to the following domains:
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Baseline outcomes measurement.
8. Baseline characteristics.
9. Other bias.
We will judge each potential source of bias as high, low, or un-
clear and provide a quote from the study report together with a
justification for our judgment in the ’Risk of bias’ table. We will
summarise the ’Risk of bias’ judgments across different studies for
each of the domains listed. We will consider blinding separately
for different key outcomes where necessary (e.g. for unblinded
outcome assessment, risk of bias for all-cause mortality may be
very different than for a self-reported pain scale).We will assess in-
complete outcome data separately for different outcomes. Where
information on risk of bias relates to unpublished data or corre-
spondence with a trialist, we will note this in the ’Risk of bias’
table. We will not exclude studies on the grounds of their risk of
bias, but will clearly report the risk of bias when presenting the
results of the studies.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
We will conduct the review according to this published protocol
and report any deviations form it in the ’Differences between pro-
tocol and review’ section of the systematic review.
Measures of treatment effect
We will estimate the effect of the intervention using risk ratio
for dichotomous data, together with the appropriate associated
95% confidence interval and standardised mean difference for
continuous data, together with the 95% appropriate associated
confidence interval (Higgins 2011).Wewill ensure that an increase
in scores for continuous outcomes can be interpreted in the same
way for each outcome, explain the direction to the reader, and
report where the directions were reversed if this was necessary.
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Unit of analysis issues
We will control for unit of analyses errors by re-analysing results
while adjusting for clustering. If there is not enough information
to re-analyse the results we will try to contact the study authors to
obtain the necessary data. If we are not able to access all the data
we will not report confidence intervals or P values (EPOC 2017c).
Dealing with missing data
Wewill contact investigators to verify key study characteristics and
obtain missing outcome data where possible (e.g. when a study
is identified as abstract only). We will try to compute missing
summary data from other reported statistics. Whenever it is not
possible to obtain data, we will report the level of missingness and
consider how that might impact the certainty of the evidence.
Assessment of heterogeneity
If we find studies that are similar enough to combine, we will
conduct a meta-analysis (Borenstein 2009). We will use the I²
statistic tomeasure heterogeneity among the trials in each analysis.
If we identify substantial heterogeneity we will explore it by pre-
specified subgroup analysis.
Assessment of reporting biases
We will attempt to contact study authors, asking them to pro-
vide missing outcome data. Where this is not possible, and the
missing data are thought to introduce serious bias, we will explore
the impact of including such studies in the overall assessment of
results. If we are able to pool more than 10 trials, we will create
and examine a funnel plot to explore possible publication biases,
interpreting the results with caution (Sterne 2011).
Data synthesis
We will undertake meta-analyses only where this is meaning-
ful, that is, if the treatments, participants, and the underlying
clinical question are similar enough for pooling to make sense
(Borenstein 2009). A common way that trialists indicate when
they have skewed data is by reporting medians and interquartile
ranges. When we encounter this we will note that the data were
skewed and consider the implication of this. Where multiple trial
arms are reported in a single trial, we will include only the rele-
vant arms. If two comparisons (e.g. intervention A versus usual
care and intervention B versus usual care) must be entered into
the same meta-analysis, we will halve the control group to avoid
double-counting.
GRADE and ’Summary of findings’ table
Two review authors will independently assess the certainty of
the evidence (high, moderate, low, and very low) using the five
GRADE considerations (risk of bias, consistency of effect, im-
precision, indirectness, and publication bias) (Guyatt 2008). We
will use methods and recommendations described in the Cochrane
Handbook for Systematic Reviews of interventions (Schünemann
2017), and the EPOC worksheets (EPOC 2017d), and using
GRADEpro software (GRADEpro GDT). We will resolve dis-
agreements on certainty ratings by discussion and provide justifica-
tion for decisions to down- or up-grade the ratings using footnotes
in the table and make comments to aid readers’ understanding of
the review where necessary. We will use plain language statements
to report these findings in the review (EPOC 2017e).
We will create ’Summary of findings’ tables for the main interven-
tion comparison(s) and include the following outcomes to draw
conclusions about the certainty of the evidence within the text of
the review: time between presentation and appropriate response
by provider; mortality and health-related quality of life; clients
acceptability of and satisfaction with the intervention; resource
use; and unintended consequences. If we find enough studies, we
will create one summary of findings table each for more com-
mon health conditions (e.g., heart failure, diabetes, mental health,
asthma). If we find enough studies, we will separate studies ac-
cording to their main function (monitoring, consulting, and de-
livering treatment).
We will consider whether there is any additional outcome infor-
mation that was not able to be incorporated into meta-analyses
and note this in the comments and state if it supports or contra-
dicts the information from the meta-analyses. If it is not possible
to meta-analyse the data we will summarise the results in the text.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses.
1. Healthcare provider type (e.g. lay versus professional
healthcare provider). Lay health workers often provide healthcare
in settings where healthcare resources are scarcer, for example
targeting epidemics in low- and middle-income countries and
the specific health needs of minority communities in high-
income countries (Lewin 2010). Because lay health workers have
no formal professional tertiary education, their knowledge and
beliefs might moderate the effects of the intervention (Akinlua
2016).
2. Type of communication channel (e.g. voice, SMS,
interactive voice response, image exchange). Different
communication channels might be used differently and serve
distinct purposes (Ventola 2014), as well as providing a more
comprehensive and realistic opportunity for communication.
3. Setting/income level (e.g. low-income versus high-income
settings). Traditionally, the quality of healthcare is lower in low-
and middle-income countries (Mills 2014), which might
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increase heterogeneity and pre-empt the pooled analysis of
studies conducted in different settings.
We will use the following outcomes in subgroup analysis.
1. Time between presentation and appropriate management
by provider, including change in time for clients to receive/access
health services and information;
2. clients’ health status and well-being; and
3. clients’ utilisation of healthcare services.
We will use the formal statistical techniques of Mantel-Haenszel
and regression to test for subgroup interactions (Mantel 1959).
Sensitivity analysis
We will perform sensitivity analyses defined a priori to assess the
robustness of our conclusions and explore its impact on effect sizes.
This will involve restricting the analysis to published studies and
restricting the analysis to studies with a low risk of bias.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
1 exp Health Personnel/
2 (((health or medical or healthcare) adj (personnel or worker* or auxiliar* or staff or professional*)) or doctor* or physician* or GP
or general practitioner? or family doctor or nurse* or midwi* or clinical officer* or pharmacist* or dentist* or ((birth or childbirth or
labor or labour) adj (attendant? or assistant?))).ti,ab,kw.
3 ((lay or voluntary or volunteer? or untrained or unlicensed or nonprofessional? or non professional?) adj5 (worker? or visitor? or
attendant? or aide or aides or support$ or person$ or helper? or carer? or caregiver? or care giver? or consultant? or assistant? or
staff )).ti,ab,kw.
4 (paraprofessional? or paramedic or paramedics or paramedical worker? or paramedical personnel or allied health personnel or allied
health worker? or support worker? or home health aide?).ti,ab,kw.
5 ((community or village? or lay) adj3 (health worker? or health care worker? or healthcare worker?)).ti,ab,kw.
6 (doula? or douladural? or barefoot doctor?).ti,ab,kw.
7 1 or 2 or 3 or 4 or 5 or 6
8 Cell Phones/
9 Smartphone/
10 MP3-Player/
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11 Computers, Handheld/
12 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw.
13 (handheld or hand-held).ti,ab,kw.
14 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw.
15 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw.
16 (samsung or nokia).ti,ab,kw.
17 (windows adj3 (mobile* or phone*)).ti,ab,kw.
18 android.ti,ab,kw.
19 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw.
20 (tablet* adj3 (device* or computer*)).ti,ab,kw.
21 Telemedicine/
22 Videoconferencing/ or Webcasts as topic/
23 Text Messaging/
24 Telenursing/
25 (mhealth or m-health or “mobile health” or ehealth or e-health or “electronic health”).ti,ab,kw.
26 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or tele-nursing or telepsychiatry or
tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-
coach*).ti,ab,kw.
27 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw.
28 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or instant messenger).ti,ab,kw.
29 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice response* or IVR or voice call* or
callback* or voice over internet or VOIP).ti,ab,kw.
30 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or “You Tube” or Google Hangout*).ti,ab,kw.
31 Mobile Applications/
32 “mobile app*”.ti,ab,kw.
33 Social Media/
34 (social adj (media or network*)).ti,ab,kw.
35 Reminder Systems/
36 (remind* adj3 (text* or system* or messag*)).ti,ab,kw.
37 Electronic Mail/
38 (electronic mail* or email* or e-mail or webmail).ti,ab,kw.
39 Medical informatics/ or Medical informatics applications/
40 Nursing informatics/ or Public health informatics/
41 ((medical or clinical or health or healthcare or nurs*) adj3 informatics).ti,ab,kw.
42 Multimedia/
43 Hypermedia/
44 Blogging/
45 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-log*).ti,ab,kw.
46 Interactive Tutorial/
47 Computer-Assisted Instruction/
48 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or software or communication)).ti,ab,kw.
49 or/8-48
50 randomized controlled trial.pt.
51 controlled clinical trial.pt.
52 randomized.ab.
53 placebo.ab.
54 drug therapy.fs.
55 randomly.ab.
56 trial.ab.
57 groups.ab.
58 or/50-57
59 exp animals/ not humans.sh.
60 58 not 59
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61 7 and 49 and 60
62 limit 61 to yr=“2000 -Current”
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